Article
Identification and credentialing of patient-derived xenograft models of invasive lobular carcinoma.
Disease models & mechanisms - 1 Apr 2026
Hooda Jagmohan, Atkinson Jennifer M, Shah Osama Shiraz, Yates Megan, Brown Daniel D, DeBerry Morgan, Cairo Stefano, Schiavini Paolo, Tsai Hsiu-Wen, Zipeto Marianna, Bhargava Rohit, Oesterreich Steffi, Lee Adrian V
Abstract excerpt
Invasive lobular cancer (ILC) is the most common special breast cancer subtype, accounting for 10-15% of all cases. The pathognomonic feature of ILC is loss of E-cadherin (encoded by CDH1), leading to discohesive single-file growth. Although ILCs show better prognostic factors than 'no special type' (NST) breast cancer, patients with ILC have worse long-term outcomes. We identified and validated patient-derived...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
